Hong Kong, China

Changdong Liu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Changdong Liu: Innovator in Therapeutic Agents

Introduction

Changdong Liu is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of therapeutic agents, particularly in addressing neurodegenerative diseases and HIV treatment. With a total of 2 patents, Liu's work showcases his dedication to advancing medical science.

Latest Patents

Liu's latest patents include innovative compositions and methods for treating various neurodegenerative diseases. His first patent focuses on compounds that target conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The invention also encompasses methods of fermentation of bacterial cells and tautomerization of the compounds. His second patent involves albofungin and its derivatives, which specifically recognize HIV-1 LTR-III G-quadruplex. This invention outlines methods for treating subjects with HIV using these compounds.

Career Highlights

Throughout his career, Changdong Liu has worked with esteemed institutions such as The Hong Kong University of Science and Technology and the Southern Marine Science and Engineering Guangdong Laboratory in Guangzhou. His research has significantly impacted the understanding and treatment of complex diseases.

Collaborations

Liu has collaborated with notable colleagues, including Aifang Cheng and Wenkang Ye. Their combined expertise has contributed to the advancement of therapeutic innovations.

Conclusion

Changdong Liu's work exemplifies the spirit of innovation in the medical field. His patents reflect a commitment to developing effective treatments for serious health conditions. Liu's contributions continue to inspire future research and development in therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…